Accumulating evidences have indicated that NSD2 also functions as an oncogene in several solid tumors, such as lung, colorectal, renal, cervical, prostate cancer, hepatocellular carcinoma, and osteosarcoma (11–17). Here, NSD2 is linked to prostate cancer.